3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
18
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
5
Neoplasms
2
Relapsed Ovarian Cancers Patients
1
Prostatic Neoplasms
1
Kenny-Caffey syndrome, Type 1
1
Hyperglycemia
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Breast Cancer Organoids
1
Interventions
Surveys and Questionnaires
16
Blood Specimen Collection
7
Observation
5
Surgical Procedures, Operative
4
Interviews as Topic
4
Hysteroscopy
4
Hysterectomy
4
Ultrasonography
2
Specimen Handling
2
Sentinel Lymph Node Biopsy
2
Reverse Transcriptase Polymerase Chain Reaction
2
Psychiatric Rehabilitation
2
Magnetic Resonance Spectroscopy
2
Laparoscopy
2
Immunohistochemistry
2
High-Energy Shock Waves
2
Drug Therapy
2
Data Collection
2
Biopsy
2
Base Sequence
2
trastuzumab deruxtecan
1
sarcolipin
1
rubitecan
1
olaparib
1
dostarlimab
1
apixaban
1
X-Rays
1
Vaginal Smears
1
Tissue Banks
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Endometrial Neoplasms
×
olaparib
×
Clear all
NCT02506816
2020-11-30
Polen
MedSIR
Completed
36 enrolled
10 charts